Active Ingredient: SELEXIPAG
Proprietary Name: UPTRAVI
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: 1.8MG/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N214275
Product Number: 001
Approval Date: Jul 29, 2021
Applicant Holder Full Name: ACTELION PHARMACEUTICALS US INC
Marketing Status:
Prescription
Patent and Exclusivity Information
